[
  {
    "title": "南新制药(688189.SH)：拟使用不超3亿元闲置募资暂时补充流动资金",
    "href": "http://stock.jrj.com.cn/2022/12/29170237246673.shtml",
    "datetime": "2022-12-29 17:02:27",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：收到兴盟生物归还的款项21237.26万元",
    "href": "http://stock.jrj.com.cn/2022/12/12175837206436.shtml",
    "datetime": "2022-12-12 17:58:35",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：终止收购兴盟生物100%股权",
    "href": "http://stock.jrj.com.cn/2022/12/08191737199242.shtml",
    "datetime": "2022-12-08 19:17:35",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：“研发实验室”项目结项和终止部分超募项目",
    "href": "http://stock.jrj.com.cn/2022/12/08184537199138.shtml",
    "datetime": "2022-12-08 18:45:28",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：拟使用超募资金1.39亿元永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2022/12/08184237199144.shtml",
    "datetime": "2022-12-08 18:42:53",
    "code": "688189"
  },
  {
    "title": "南新制药(688189)：持股5%以上股东提前终止减持计划暨减持股份结果",
    "href": "http://stock.jrj.com.cn/2022/09/22091637013058.shtml",
    "datetime": "2022-09-22 09:16:55",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：鼎晖投资拟提前终止减持计划 已共计减持4%股份",
    "href": "http://stock.jrj.com.cn/2022/09/21171437011469.shtml",
    "datetime": "2022-09-21 17:14:07",
    "code": "688189"
  },
  {
    "title": "南新制药：控股股东湘投集团拟将5600万股无偿划转至医药发展集团",
    "href": "http://stock.jrj.com.cn/2022/09/05103436972865.shtml",
    "datetime": "2022-09-05 10:34:16",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：湘投集团拟无偿划转公司28.57%股权至新组建的医药发展集团",
    "href": "http://stock.jrj.com.cn/2022/09/04160536971910.shtml",
    "datetime": "2022-09-04 16:05:07",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：上半年归母净利减57.68%至1781.18万元",
    "href": "http://stock.jrj.com.cn/2022/08/30170936953084.shtml",
    "datetime": "2022-08-30 17:09:36",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：控股股东正筹划战略重组、控股股东可能发生变更",
    "href": "http://stock.jrj.com.cn/2022/08/28153336944097.shtml",
    "datetime": "2022-08-28 15:33:00",
    "code": "688189"
  },
  {
    "title": "南新制药(688189)：持股5%以上股东减持股份时间过半暨减持进展",
    "href": "http://stock.jrj.com.cn/2022/06/28091036763194.shtml",
    "datetime": "2022-06-28 09:10:27",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：减持期过半 鼎晖投资累计减持1.43%股份",
    "href": "http://stock.jrj.com.cn/2022/06/27180436761907.shtml",
    "datetime": "2022-06-27 18:04:25",
    "code": "688189"
  },
  {
    "title": "A股异动 | 南新制药(688189.SH)跌超7% 遭股东减持1%股份",
    "href": "http://stock.jrj.com.cn/2022/05/24143436673821.shtml",
    "datetime": "2022-05-24 14:34:08",
    "code": "688189"
  },
  {
    "title": "南新制药(688189)：持股5%以上股东减持比例达到1%",
    "href": "http://stock.jrj.com.cn/2022/05/24090036672661.shtml",
    "datetime": "2022-05-24 09:00:23",
    "code": "688189"
  },
  {
    "title": "南新制药：股东杭州鼎晖累计减持140万股 占公司总股本比例1%",
    "href": "http://stock.jrj.com.cn/2022/05/23182936671274.shtml",
    "datetime": "2022-05-23 18:29:59",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：鼎晖投资自5月6日起累计减持1%股份",
    "href": "http://stock.jrj.com.cn/2022/05/23170836670676.shtml",
    "datetime": "2022-05-23 17:08:44",
    "code": "688189"
  },
  {
    "title": "说明公司业绩波动的合理性？南新制药回复年报问询函",
    "href": "http://stock.jrj.com.cn/2022/05/16102236650239.shtml",
    "datetime": "2022-05-16 10:22:52",
    "code": "688189"
  },
  {
    "title": "南新制药上市后连续2年业绩“变脸”：上交所要求说明亏损原因和合理性",
    "href": "http://stock.jrj.com.cn/2022/05/16091236649848.shtml",
    "datetime": "2022-05-16 09:12:53",
    "code": "688189"
  },
  {
    "title": "南新制药披露2022年一季报 实现营收1.97亿元",
    "href": "http://stock.jrj.com.cn/2022/05/05085236565927.shtml",
    "datetime": "2022-05-05 08:52:42",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：140万股限售股将于3月28日解禁上市",
    "href": "http://stock.jrj.com.cn/2022/03/18172534845844.shtml",
    "datetime": "2022-03-18 17:25:16",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：鼎晖投资拟减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2022/03/04171534530626.shtml",
    "datetime": "2022-03-04 17:15:14",
    "code": "688189"
  },
  {
    "title": "南新制药2021年亏损1.76亿同比由盈转亏 产品销售收入减少",
    "href": "http://stock.jrj.com.cn/2022/02/27211234489262.shtml",
    "datetime": "2022-02-27 21:12:40",
    "code": "688189"
  },
  {
    "title": "南新制药2021年预计亏损1亿-2亿同比由盈转亏 产品“辛可”销售收入较20年减少",
    "href": "http://stock.jrj.com.cn/2022/01/29143134257067.shtml",
    "datetime": "2022-01-29 14:31:49",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：2021年度预亏1亿元-2亿元",
    "href": "http://stock.jrj.com.cn/2022/01/28212134248769.shtml",
    "datetime": "2022-01-28 21:21:08",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：减持数过半 鼎晖投资累计减持1%股份",
    "href": "http://stock.jrj.com.cn/2022/01/20181134179338.shtml",
    "datetime": "2022-01-20 18:11:57",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：拟使用不超3亿元闲置募集资金暂时补充流动资金",
    "href": "http://stock.jrj.com.cn/2022/01/13173034154608.shtml",
    "datetime": "2022-01-13 17:30:01",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)： 鼎晖投资自12月15日起累计减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/12/30170734087193.shtml",
    "datetime": "2021-12-30 17:07:54",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：持股5%以上股东已减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/11/30185733945312.shtml",
    "datetime": "2021-11-30 18:57:13",
    "code": "688189"
  },
  {
    "title": "重组事项推进是否存在实质性障碍？南新制药回复科创板问询函",
    "href": "http://stock.jrj.com.cn/2021/11/17131233865663.shtml",
    "datetime": "2021-11-17 13:12:17",
    "code": "688189"
  },
  {
    "title": "收购事项遭问询，南新制药需要回复这些问题",
    "href": "http://stock.jrj.com.cn/2021/11/09134633827372.shtml",
    "datetime": "2021-11-09 13:46:00",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：减持期过半 鼎晖投资未减持公司股份",
    "href": "http://stock.jrj.com.cn/2021/11/07162833820179.shtml",
    "datetime": "2021-11-07 16:28:24",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)第三季度净利润706.1万元 同比下降67.24%",
    "href": "http://stock.jrj.com.cn/2021/10/29171933778191.shtml",
    "datetime": "2021-10-29 17:19:13",
    "code": "688189"
  },
  {
    "title": "破发股南新制药股价低迷 上市超募4.7亿经营现金流连负",
    "href": "http://stock.jrj.com.cn/2021/09/30152533542920.shtml",
    "datetime": "2021-09-30 15:25:00",
    "code": "688189"
  },
  {
    "title": "南新制药2021年半年度净利4209万元 同比净利减少15.00%",
    "href": "http://stock.jrj.com.cn/2021/08/31123333359929.shtml",
    "datetime": "2021-08-31 12:33:24",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：上半年净利降15%至4209万元",
    "href": "http://stock.jrj.com.cn/2021/08/30204333354948.shtml",
    "datetime": "2021-08-30 20:43:08",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)2020年度权益分派10派2.91元 股权登记日为8月16日",
    "href": "http://stock.jrj.com.cn/2021/08/10163233231895.shtml",
    "datetime": "2021-08-10 16:32:20",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：拟使用不超3亿元闲置募集资金暂时补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/07/21191733131082.shtml",
    "datetime": "2021-07-21 19:17:55",
    "code": "688189"
  },
  {
    "title": "因基金期限原因 南新制药股东鼎晖投资计划减持不超过840万股",
    "href": "http://stock.jrj.com.cn/2021/07/15104333100216.shtml",
    "datetime": "2021-07-15 10:43:41",
    "code": "688189"
  },
  {
    "title": "南新制药重大资产重组方案获得湖南省国资委批复",
    "href": "http://stock.jrj.com.cn/2021/05/12105132740821.shtml",
    "datetime": "2021-05-12 10:51:10",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：重大资产重组方案获湖南省国资委批复",
    "href": "http://stock.jrj.com.cn/2021/05/11164832735988.shtml",
    "datetime": "2021-05-11 16:48:22",
    "code": "688189"
  },
  {
    "title": "南新制药去年盈利1.33亿元 拟派现4074万元",
    "href": "http://stock.jrj.com.cn/2021/03/29110532239495.shtml",
    "datetime": "2021-03-29 11:05:47",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：拟使用不超8.5亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/03/28123232228910.shtml",
    "datetime": "2021-03-28 12:32:26",
    "code": "688189"
  },
  {
    "title": "南新制药2020年净利1.33亿增长45%：董事长杨文逊薪酬156万",
    "href": "http://stock.jrj.com.cn/2021/03/27090832226768.shtml",
    "datetime": "2021-03-27 09:08:31",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：2021年度拟申请不超6.5亿元综合授信",
    "href": "http://stock.jrj.com.cn/2021/03/26221632224828.shtml",
    "datetime": "2021-03-26 22:16:50",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)拟以部分超募资金投建“帕拉米韦生产基地三期工程项目”变更为“NX-2016”等5个项目",
    "href": "http://stock.jrj.com.cn/2021/03/26221132224819.shtml",
    "datetime": "2021-03-26 22:11:05",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：核心技术人员游志毅离职",
    "href": "http://stock.jrj.com.cn/2021/03/26220432224805.shtml",
    "datetime": "2021-03-26 22:04:01",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：2020年度净利升45.37%至1.33亿元 拟10派2.91元",
    "href": "http://stock.jrj.com.cn/2021/03/26185032223869.shtml",
    "datetime": "2021-03-26 18:50:46",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：6500万股首发限售股3月26日解禁",
    "href": "http://stock.jrj.com.cn/2021/03/17162732151362.shtml",
    "datetime": "2021-03-17 16:27:59",
    "code": "688189"
  },
  {
    "title": "南新制药2020年度净利1.33亿增长45.37% 产品销售结构、综合毛利率提升",
    "href": "http://stock.jrj.com.cn/2021/02/27111832037897.shtml",
    "datetime": "2021-02-27 11:18:56",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)业绩快报：2020年净利升45.37%至1.33亿元",
    "href": "http://stock.jrj.com.cn/2021/02/26161232033169.shtml",
    "datetime": "2021-02-26 16:12:51",
    "code": "688189"
  },
  {
    "title": "南新制药：核心技术人员缪栋离职，其工作由杜松接手",
    "href": "http://stock.jrj.com.cn/2021/02/02092531834657.shtml",
    "datetime": "2021-02-02 09:25:58",
    "code": "688189"
  },
  {
    "title": "获高新企业重新认定，南新制药：税收优惠不影响2020年度数据",
    "href": "http://stock.jrj.com.cn/2021/01/27090431785951.shtml",
    "datetime": "2021-01-27 09:04:52",
    "code": "688189"
  },
  {
    "title": "全资子公司被认定为高新企业 A股“新兵”南新制药再接再厉",
    "href": "http://stock.jrj.com.cn/2021/01/04084331625177.shtml",
    "datetime": "2021-01-04 08:43:00",
    "code": "688189"
  },
  {
    "title": "全资子公司被认定为高新企业 A股“新兵”南新制药再接再厉",
    "href": "http://stock.jrj.com.cn/2021/01/04084331650760.shtml",
    "datetime": "2021-01-04 08:43:00",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：全资子公司获得高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2020/12/31154231612555.shtml",
    "datetime": "2020-12-31 15:42:55",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：6名董事及高管质押间接持有的414.36万股",
    "href": "http://stock.jrj.com.cn/2020/12/30220031607234.shtml",
    "datetime": "2020-12-30 22:00:40",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)拟以不超2.5亿元闲置募集资金暂时补充流动资金",
    "href": "http://stock.jrj.com.cn/2020/11/24211331341233.shtml",
    "datetime": "2020-11-24 21:13:10",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)拟投资3.26亿元超募资金建设帕拉米韦生产基地三期工程项目",
    "href": "http://stock.jrj.com.cn/2020/11/24211131341234.shtml",
    "datetime": "2020-11-24 21:11:58",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：拟使用超募资金1.39亿元用于永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2020/11/24211131341235.shtml",
    "datetime": "2020-11-24 21:11:49",
    "code": "688189"
  },
  {
    "title": "南新制药溢价472倍收购兴盟苏州 并购扩充产品线拓展创新药版图",
    "href": "http://stock.jrj.com.cn/2020/11/11082231257095.shtml",
    "datetime": "2020-11-11 08:22:24",
    "code": "688189"
  },
  {
    "title": "26.7亿元谋购兴盟苏州 南新制药加码创新药业务",
    "href": "http://stock.jrj.com.cn/2020/11/10023031244252.shtml",
    "datetime": "2020-11-10 02:30:00",
    "code": "688189"
  },
  {
    "title": "472倍！南新制药拟超高溢价收购研发药企，标的仅两款产品进入临床三期",
    "href": "http://stock.jrj.com.cn/2020/11/09181431242161.shtml",
    "datetime": "2020-11-09 18:14:32",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：收到上交所对公司重大资产重组预案的问询函",
    "href": "http://stock.jrj.com.cn/2020/11/08184531237486.shtml",
    "datetime": "2020-11-08 18:45:42",
    "code": "688189"
  },
  {
    "title": "南新制药(688189.SH)：拟购买兴盟苏州100%股权 11月9日复牌",
    "href": "http://stock.jrj.com.cn/2020/11/08145531236956.shtml",
    "datetime": "2020-11-08 14:55:47",
    "code": "688189"
  },
  {
    "title": "南新制药：拟以不超26.72亿元购买兴盟苏州100%股权",
    "href": "http://stock.jrj.com.cn/kcb/2020/11/08141431236881.shtml",
    "datetime": "2020-11-08 14:14:33",
    "code": "688189"
  },
  {
    "title": "南新制药前三季度净利7107.29万增长51.03% 创新药帕拉米韦氯化钠注射液收入增加",
    "href": "http://stock.jrj.com.cn/2020/10/29091131155641.shtml",
    "datetime": "2020-10-29 09:11:53",
    "code": "688189"
  },
  {
    "title": "南新制药：筹划重大资产重组停牌的公告",
    "href": "http://stock.jrj.com.cn/2020/10/24001031119664.shtml",
    "datetime": "2020-10-24 00:10:02",
    "code": "688189"
  },
  {
    "title": "南新制药：正在筹划购买兴盟苏州的股权事项 股票停牌",
    "href": "http://stock.jrj.com.cn/2020/10/23221731119295.shtml",
    "datetime": "2020-10-23 22:17:38",
    "code": "688189"
  },
  {
    "title": "南新制药：首次公开发行网下配售限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2020/09/18001030772399.shtml",
    "datetime": "2020-09-18 00:10:02",
    "code": "688189"
  },
  {
    "title": "南新制药：公司的在研新药有美他非尼、盐酸美氟尼酮",
    "href": "http://stock.jrj.com.cn/2020/09/17161430770039.shtml",
    "datetime": "2020-09-17 16:14:00",
    "code": "688189"
  },
  {
    "title": "股价或还涨58%！抗流感“新星”南新制药新品增强核心竞争力",
    "href": "http://stock.jrj.com.cn/2020/09/15073930752801.shtml",
    "datetime": "2020-09-15 07:39:00",
    "code": "688189"
  },
  {
    "title": "股价或还涨58%！抗流感“新星”南新制药新品增强核心竞争力",
    "href": "http://stock.jrj.com.cn/2020/09/15073930789086.shtml",
    "datetime": "2020-09-15 07:39:00",
    "code": "688189"
  },
  {
    "title": "南新制药头孢克洛胶囊拟中标第三批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/08/21224230560618.shtml",
    "datetime": "2020-08-21 22:42:41",
    "code": "688189"
  },
  {
    "title": "电鳗财经|中报净利润增四成 南新制药加大研发要做抗流感的“老大”",
    "href": "http://stock.jrj.com.cn/invest/2020/08/21090030555936.shtml",
    "datetime": "2020-08-21 09:00:00",
    "code": "688189"
  },
  {
    "title": "中报净利润增四成 南新制药加大研发要做抗流感的“老大”",
    "href": "http://stock.jrj.com.cn/2020/08/21085530555935.shtml",
    "datetime": "2020-08-21 08:55:00",
    "code": "688189"
  },
  {
    "title": "南新制药2020年上半年净利4951.63万增长40.97% 销售额增加",
    "href": "http://stock.jrj.com.cn/2020/08/18124030528831.shtml",
    "datetime": "2020-08-18 12:40:20",
    "code": "688189"
  },
  {
    "title": "南新制药帕拉米韦吸入溶液获临床试验通知",
    "href": "http://stock.jrj.com.cn/2020/06/01194129817282.shtml",
    "datetime": "2020-06-01 19:41:58",
    "code": "688189"
  },
  {
    "title": "南新制药2020年第一季度净利2637.87万增长28.22% 创新药帕拉米韦氯化钠注射液收入增加",
    "href": "http://stock.jrj.com.cn/2020/04/30200129434572.shtml",
    "datetime": "2020-04-30 20:01:24",
    "code": "688189"
  },
  {
    "title": "南新制药：一季度实现净利2637.87万元 同比增长28.22%",
    "href": "http://stock.jrj.com.cn/2020/04/28215529408170.shtml",
    "datetime": "2020-04-28 21:55:00",
    "code": "688189"
  },
  {
    "title": "3月26日新股提示：三友医疗、雷赛智能申购 南新制药上市 测绘股份、和顺石油公布中签率",
    "href": "http://stock.jrj.com.cn/ipo/2020/03/26084229115453.shtml",
    "datetime": "2020-03-26 08:42:28",
    "code": "688189"
  },
  {
    "title": "南新制药今日上市 发行价格34.94元/股",
    "href": "http://stock.jrj.com.cn/ipo/2020/03/26082329115350.shtml",
    "datetime": "2020-03-26 08:23:24",
    "code": "688189"
  },
  {
    "title": "科创板南新制药中签号出炉 共26670个",
    "href": "http://stock.jrj.com.cn/2020/03/17191429046584.shtml",
    "datetime": "2020-03-17 19:14:00",
    "code": "688189"
  },
  {
    "title": "【兑奖啦】南新制药网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2020/03/17190729046484.shtml",
    "datetime": "2020-03-17 19:07:38",
    "code": "688189"
  },
  {
    "title": "南新制药：回拨机制启动后 上发行最终中签率为0.04241916％",
    "href": "http://stock.jrj.com.cn/ipo/2020/03/16192329034727.shtml",
    "datetime": "2020-03-16 19:23:34",
    "code": "688189"
  },
  {
    "title": "今日新股申购：南新制药",
    "href": "http://stock.jrj.com.cn/2020/03/16085629029612.shtml",
    "datetime": "2020-03-16 08:56:00",
    "code": "688189"
  },
  {
    "title": "新股提示：南新制药今日申购",
    "href": "http://stock.jrj.com.cn/2020/03/16070229028676.shtml",
    "datetime": "2020-03-16 07:02:00",
    "code": "688189"
  },
  {
    "title": "科创板新股南新制药3月16日申购宝典",
    "href": "http://stock.jrj.com.cn/kcb/2020/03/13141929019448.shtml",
    "datetime": "2020-03-13 14:19:16",
    "code": "688189"
  },
  {
    "title": "南新制药03月16日申购宝典",
    "href": "http://stock.jrj.com.cn/kcb/2020/03/13141529019435.shtml",
    "datetime": "2020-03-13 14:15:33",
    "code": "688189"
  },
  {
    "title": "南新制药：创新药快速放量 2019年业绩大幅增长",
    "href": "http://stock.jrj.com.cn/2020/03/10163528991987.shtml",
    "datetime": "2020-03-10 16:35:25",
    "code": "688189"
  },
  {
    "title": "证监会同意南新制药科创板IPO注册",
    "href": "http://stock.jrj.com.cn/2020/02/25194828892097.shtml",
    "datetime": "2020-02-25 19:48:00",
    "code": "688189"
  },
  {
    "title": "南新制药将加大新药研发投入",
    "href": "http://stock.jrj.com.cn/kcb/2020/02/13024528818465.shtml",
    "datetime": "2020-02-13 02:45:01",
    "code": "688189"
  },
  {
    "title": "科创板拟上市公司南新制药获上市委会议通过",
    "href": "http://stock.jrj.com.cn/2020/02/05171628776915.shtml",
    "datetime": "2020-02-05 17:16:00",
    "code": "688189"
  },
  {
    "title": "南新制药科创板过会：利润增长快研发投入低 仿制药风险需警惕",
    "href": "http://stock.jrj.com.cn/kcb/2020/01/17073228690333.shtml",
    "datetime": "2020-01-17 07:32:45",
    "code": "688189"
  },
  {
    "title": "上交所：德马科技、南新制药科创板首发过会",
    "href": "http://stock.jrj.com.cn/2020/01/14170728675806.shtml",
    "datetime": "2020-01-14 17:07:00",
    "code": "688189"
  },
  {
    "title": "南新制药：第一大产品新药证书系与第三方共有 在国内市场的市场份额较低",
    "href": "http://stock.jrj.com.cn/2020/01/06121428630569.shtml",
    "datetime": "2020-01-06 12:14:45",
    "code": "688189"
  },
  {
    "title": "科创板上市委：德马科技、南新制药首发1月14日上会",
    "href": "http://stock.jrj.com.cn/2020/01/03170728625091.shtml",
    "datetime": "2020-01-03 17:07:00",
    "code": "688189"
  },
  {
    "title": "每经小强快讯：前往科创板再下一城，湖南南新制药股份有限公司已获上交所问询",
    "href": "http://stock.jrj.com.cn/2019/07/24185627882896.shtml",
    "datetime": "2019-07-24 18:56:10",
    "code": "688189"
  },
  {
    "title": "南新制药欲上科创板 产能利用率不高受关注",
    "href": "http://stock.jrj.com.cn/kcb/2019/07/08043227806697.shtml",
    "datetime": "2019-07-08 04:32:28",
    "code": "688189"
  },
  {
    "title": "每经小强快讯：湖南南新制药股份有限公司科创板首次公开发行股票招股说明书（申报稿）",
    "href": "http://stock.jrj.com.cn/2019/06/26170327759040.shtml",
    "datetime": "2019-06-26 17:03:09",
    "code": "688189"
  },
  {
    "title": "每经小强快讯：进军科创板，湖南南新制药股份有限公司申请已获上交所受理",
    "href": "http://stock.jrj.com.cn/2019/06/26170127759022.shtml",
    "datetime": "2019-06-26 17:01:20",
    "code": "688189"
  }
]